Serum free thyroxin (FT4) was determined in 40 patients with various nonthyroidal illnesses. We studied seven methods: (1) a free thyroxin index calculated from total T4 and triiodothyronine resin uptake; (2) a free T4 index determined by enzyme inhibitor assays (Abbott's "Tetrazyme" and "Thyrozyme"); (3) a free T4 index calculated from total T4 and thyroxin-binding globulin; (4) free T4 by equilibrium dialysis; Approximately half of the free T4 results were in the euthyroid range and the other half in the hypothyroid range by methods 1, 2, 5, and 6. Results for free T4 by methods 3 and 7 were similar to those by equilibrium dialysis (method 4), the percentages of patients with results in the euthyroid range being 68%, 65%, and 76%, respectively. and triiodothyronine (T3) as well as a lower free thyroxin index (VP4!) and free triiodothyronine index (VI'31). The extent to which the T4 value is below normal is about the same as that seen in patients with primary hypothyroidism. On the other hand, the concentration of "reverse" T3 (rT3) is generally increased (1). The FTI as calculated from T4 and T3 uptake test (T3RU) tends to give values in the hypothyroid range (2). The VP4 by equilibrium dialysis yields euthyroid values in most such patients, but occasionally produces some results in the hyperthyroid and hypothyroid ranges (3). VP4 by various RIAs (FF4-RIA) reportedly are nonspecific, giving results in the hypothyroid, euthyroid, or hyperthyroid ranges (4-7). In this study, we chose a classical test for T3RU, a new nomsotopic enzyme inhibitor assay involving T4 uptake to assess TBG (Abbott's "Thyrozyme"), a new "sandwich" TBG RIA (Clinical Assays), equilibrium dialysis as used by a well-established reference laboratory, two new VP4 RIAs involving a similar modified T4 tracer method
and triiodothyronine (T3) as well as a lower free thyroxin index (VP4!) and free triiodothyronine index (VI'31). The extent to which the T4 value is below normal is about the same as that seen in patients with primary hypothyroidism. On the other hand, the concentration of "reverse" T3 (rT3) is generally increased (1). The FTI as calculated from T4 and T3 uptake test (T3RU) tends to give values in the hypothyroid range (2). The VP4 by equilibrium dialysis yields euthyroid values in most such patients, but occasionally produces some results in the hyperthyroid and hypothyroid ranges (3). VP4 by various RIAs (FF4-RIA) reportedly are nonspecific, giving results in the hypothyroid, euthyroid, or hyperthyroid ranges (4) (5) (6) (7) . In this study, we chose a classical test for T3RU, a new nomsotopic enzyme inhibitor assay involving T4 uptake to assess TBG (Abbott's "Thyrozyme"), a new "sandwich" TBG RIA (Clinical Assays), equilibrium dialysis as used by a well-established reference laboratory, two new VP4 RIAs involving a similar modified T4 tracer method (Amersham's and Clinical Assays' one-step RIAs) and an established twostep VP4 RIA (Clinical Assays). We compared these seven methods in assessing the thyroid function of NTI patients.
Materials and Methods
We used the following methods in this study: The reference intervals for this study were determined from data on a group of 100 clinically defined euthyroid patients, except for VF4-dialysis, where the reference intervals supplied by BioScience Labs, were used (Table 1) .
Forty patients with various severe nonthyroid illnesses admitted to the medical, surgical, or coronary intensive-care units were studied prospectively.
These patients, selected without conscious bias, were patients for whom samples were submitted for evaluation of thyroid function. Their illnesses included underlying diseases such as cancer, diabetes mellitus, coronary artery disease, arteriosclerosis, parenchymal liver disease, and infection, and complications such as cardiac failure, renal failure, acute respiratory failure, and acidosis. For most of the patients, thyrotropin concentrations were within the normal reference interval (0-7 milli-int. units/L) and they had no history of either thyroid disease or pituitary disease. 
Results

Discussion
Evaluation of thyroid status in patients with systemic NT! is rather difficult. The complications of stress, drug therapy, and various diseases affect the testing of hypothalamic-pituitary-thyroid function.
In patients having a variety of severe NTI, values for T4 and T3 are greatly depressed, to the range seen in patients with primary hypothyroidism; however, thyrotropin falls within the normal range (8). The extremely low T3 and increased i'P3 values during the course of disease may represent an attempt by the body to conserve energy by switching the peripheral production to r'F3 rather than the more potent T3, probably by inhibiting the enzyme 5'-deiodinase (EC 1.11.1.8), which catalyzes the conversion ofT4 to T3 (1). Results of TBG assay, used in place of T3RU, better normalize 14 in thyroid patients, especially when TBG concentrations are extremely low or high (9) . We found that the VrI-TBG (method 3) gave FT4 estimates closest to those by the dialysis method (method 4), with most (68%) falling within the euthyroid range. However, method 3 may not perform equally well in other types of patients.
Historically
In fact, in a group of clinically euthyroid patients, VFI-TBG has recently been shown to be less reliable than VFI-RIA (10).
We reported earlier (11) that the Amerlex FT4 test gave VP4 values in the borderline hypothyroid range for NTI patients. Recently, Clinical Assays introduced a direct, onestep RIA for free T4 (method 6) involving a technology similar to that of the Amersham assay. Results for this FT4
were very similar to those of Amersham's VP4. The modified tracer method can be expected to produce minimum perturbation of the equilibrium between Fr4 and TBG-bound T4, so that one would expect the assay to measure the "true" VP4 concentration; on the other hand, the binding of the modified tracer to thyroxin-binding prealbumin and albumin becomes much more significant. This, coupled with no separation step, would present a greater potential for interference by plasma components.
Clinical Assays' VP4 twostep method (method 7) gave results closer to those by equilibrium dialysis (method 4), but both methods gave hyperthyroid results for NTI patients who had no other indication of hyperthyroidism. hnmunoextraction perturbs the equilibrium between VP4 and the binding proteins, so one might expect to see overall higher results, which indeed is what we found. In addition, we have found this method to be less precise in our laboratory.
The dialysis method, though often considered a "refer- (12) , in an attempt to explain such findings, proposed that the serum of some NT! patients may contain an inhibitor for thyroid hormone binding, which, inside the dialysis cell, would prevent binding of T4 to TBG and thereby increase the apparent VP4. An alternative explanation may be the nonlinear relation between the percentage of T4 dialyzed and low concentrations of TBG. This nonlinearity may also result in an increase of the calculated value of VP4 (8) .
In assessing the thyroid status of NT! patients, especially those with extremely severe illness, by use of laboratory tests, the various VP4 determinations may be confusing, particularly in the borderline hypothyroid range. In such patients, measurement of thyrotropin remains one of the most helpful tests, distinguishing the true hypothyroid from other patients. Further clinical studies with thyroliberin stimulation tests may give us additional insight in assessing the patient's thyroid function.
